The Union Health Ministry has revoked the Schedule K exemption for medicinal products containing over 12% ethyl alcohol in quantities exceeding 30 ml, requiring licenses and prescriptions for their sale. The move targets formulations like cough syrups and tonics, which previously bypassed licensing under Schedule K of the Drugs Rules, 1945.
Regulatory Shift for High-Alcohol Medicinal Products
Products with alcohol concentrations as high as 80–90%—such as cardamom and ginger tinctures—were previously sold without oversight, leading to misuse for intoxication. The amendment now classifies these under Schedule H1, enforcing stricter controls, including mandatory prescriptions and record-keeping.
The Ministry cited reports from state governments about the diversion of these products for non-medicinal use. Homeopathy medicines, already regulated, remain unaffected by the change.
Industry Impact and Compliance
Regulatory experts note the change will affect a range of products where alcohol serves as a solvent or stabilizer, including:
- Cough syrups
- Digestive syrups
- Tonics
The Ministry expects the amendment to strengthen pharmaceutical supply chain oversight, reducing diversion while preserving legitimate therapeutic access.
